Haisco Pharmaceutical Group Co., Ltd.

This study tested an experimental drug called HSK31679 in 186 Chinese adults with non-alcoholic steatohepatitis (NASH), a serious liver condition. Participants took either 80 mg, 160 mg, or a placebo daily for 52 weeks. The goal was to see if the drug could improve liver damage a…

This study tested a new drug called HSK39297 in 87 adults with IgA nephropathy, a kidney disease. The goal was to see if the drug could lower protein levels in urine, a sign of kidney damage, compared to a placebo. Participants took the drug or placebo for up to 24 weeks, and res…

This phase 2 trial tested an experimental tablet called HSK44459 in 186 adults with idiopathic pulmonary fibrosis (IPF), a progressive lung-scarring disease. Participants took one of three doses of the drug or a placebo twice daily for 12 weeks. The main goal was to see if the dr…

This Phase 3 study tested a new inhaler called HL231 in 487 Chinese adults with moderate to very severe COPD. Participants used either HL231 or the active comparator Ultibro once daily for 52 weeks. The main goal was to see if HL231 improved lung function (FEV1) after 26 weeks co…

This study tested a new tablet called HSK39297 in 36 adults with paroxysmal nocturnal hemoglobinuria (PNH) who still had anemia despite stable treatment with anti-C5 antibodies. The goal was to see if the pill could raise hemoglobin levels and reduce the need for blood transfusio…

This study tested a new pill called HSK39297 against a standard infusion drug (eculizumab) in 73 adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder that destroys red blood cells. Participants had not received prior complement inhibitor treatment. The mai…

This study tested a new pain-relief injection called HSK21542 in 161 adults who had hip replacement surgery. The goal was to see if it works better than a placebo or morphine at reducing pain after the operation. The results could lead to a new option for managing pain after orth…

This study tested the long-term safety and effectiveness of HSK16149, a drug for nerve pain, in 301 Chinese patients over 52 weeks. All participants had previously completed a shorter trial and tolerated the drug. Researchers tracked side effects and pain scores to see if the dru…

This completed Phase 1 trial compared a generic tenofovir disoproxil fumarate tablet to the brand-name Viread in 47 healthy Chinese adults. Participants took a single 300 mg dose under fasting or fed conditions to see if the generic version is absorbed similarly. The study focuse…

This study tested whether a generic lidocaine and prilocaine cream works the same as the brand-name EMLA® cream. Forty healthy adults had each cream applied to their thigh on separate days, and researchers measured how much of the drug got into their blood. The goal was to check …

This study tested whether a new generic version of pramipexole extended-release tablets works the same as the brand-name drug (MIRAPEX ER) in 49 healthy Chinese adults. Participants took a single dose of either the generic or brand-name drug, and researchers measured drug levels …

This early-stage trial tested how taking the experimental drug HSK47388 with or without food changes its levels in the body. Fifteen healthy adults took the drug under different meal conditions. The goal was to learn the best way to take the drug and check for side effects.